Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis

Cancer Cell

Volumn 24, Issue 4, 2013, Pages 542-556

  Ell, Brian ^a   Mercatali, Laura ^b   Ibrahim, Toni ^b   Campbell, Neil ^c   Schwarzenbach, Heidi ^d   Pantel, Klaus ^d   Amadori, Dino ^b   Kang, Yibin ^a,c  

^a PRINCETON UNIVERSITY   (United States)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 16; MICRORNA 378; OSTEOCLAST DIFFERENTIATION FACTOR; SMALL UNTRANSLATED RNA; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 84885368280     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.09.008     Document Type: Article

References (41)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Blanco M.A., LeRoy G., Khan Z., Alečković M., Zee B.M., Garcia B.A., Kang Y. Global secretome analysis identifies novel mediators of bone metastasis. Cell Res. 2012, 22:1339-1355.
3. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
4. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
5. Chaffer C.L., Dopheide B., McCulloch D.R., Lee A.B., Moseley J.M., Thompson E.W., Williams E.D. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin. Exp. Metastasis 2005, 22:115-125.
6. Clézardin P. Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res. 2011, 13:207.
7. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
8. Davey R.A., Turner A.G., McManus J.F., Chiu W.S., Tjahyono F., Moore A.J., Atkins G.J., Anderson P.H., Ma C., Glatt V., et al. Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J.Bone Miner. Res. 2008, 23:1182-1193.
9. Ell B., Kang Y. SnapShot: bone metastasis. Cell 2012, 151:690-691.
10. Flamini E., Mercatali L., Nanni O., Calistri D., Nunziatini R., Zoli W., Rosetti P., Gardini N., Lattuneddu A., Verdecchia G.M., Amadori D. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin. Cancer Res. 2006, 12:6985-6988.
11. Gonzalo P., Guadamillas M.C., Hernández-Riquer M.V., Pollán A., Grande-García A., Bartolomé R.A., Vasanji A., Ambrogio C., Chiarle R., Teixidó J., et al. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev. Cell 2010, 18:77-89.
12. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
13. Harada H., Kukita T., Kukita A., Iwamoto Y., Iijima T. Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Endocrinology 1998, 139:3967-3975.
14. Hemingway F., Taylor R., Knowles H.J., Athanasou N.A. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011, 48:938-944.
15. Hershey C.L., Fisher D.E. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone 2004, 34:689-696.
16. Hodgkinson C.A., Moore K.J., Nakayama A., Steingrímsson E., Copeland N.G., Jenkins N.A., Arnheiter H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993, 74:395-404.
17. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999, 99:81-92.
18. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordón-Cardo C., Guise T.A., Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
19. Kettritz R., Choi M., Rolle S., Wellner M., Luft F.C. Integrins and cytokines activate nuclear transcription factor-kappaB in human neutrophils. J.Biol. Chem. 2004, 279:2657-2665.
20. Kim C.H., Lee K.H., Lee C.T., Kim Y.W., Han S.K., Shim Y.S., Yoo C.G. Aggregation of beta2 integrins activates human neutrophils through the IkappaB/NF-kappaB pathway. J.Leukoc. Biol. 2004, 75:286-292.
21. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
22. Korpal M., Yan J., Lu X., Xu S., Lerit D.A., Kang Y. Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat. Med. 2009, 15:960-966.
23. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
24. Kurachi T., Morita I., Murota S. Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Biochim. Biophys. Acta 1993, 1178:259-266.
25. Le X.F., Merchant O., Bast R.C., Calin G.A. The roles of microRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron. 2010, 3:137-147.
26. Lelekakis M., Moseley J.M., Martin T.J., Hards D., Williams E., Ho P., Lowen D., Javni J., Miller F.R., Slavin J., Anderson R.L. A novel orthotopic model of breast cancer metastasis to bone. Clin. Exp. Metastasis 1999, 17:163-170.
27. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S., et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999, 13:1015-1024.
28. Lu X., Mu E., Wei Y., Riethdorf S., Yang Q., Yuan M., Yan J., Hua Y., Tiede B.J., Lu X., et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell 2011, 20:701-714.
29. Mann M., Barad O., Agami R., Geiger B., Hornstein E. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc. Natl. Acad. Sci. USA 2010, 107:15804-15809.
30. Mizoguchi F., Izu Y., Hayata T., Hemmi H., Nakashima K., Nakamura T., Kato S., Miyasaka N., Ezura Y., Noda M. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J.Cell. Biochem. 2010, 109:866-875.
31. Nakano K., Okada Y., Saito K., Tanaka Y. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. Arthritis Rheum. 2004, 50:2450-2458.
32. Quattrocchi C.C., Dell'Aia P., Errante Y., Occhicone F., Longo D., Virzì V., Tonini G., Napoli N., Santini D., Zobel B.B. Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases. J.Bone Oncol. 2012, 1:24-29.
33. Sethi N., Dai X., Winter C.G., Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 2011, 19:192-205.
34. Sharma S.M., Bronisz A., Hu R., Patel K., Mansky K.C., Sif S., Ostrowski M.C. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J.Biol. Chem. 2007, 282:15921-15929.
35. Sugatani T., Hruska K.A. MicroRNA-223 is a key factor in osteoclast differentiation. J.Cell. Biochem. 2007, 101:996-999.
36. Sugatani T., Hruska K.A. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J.Biol. Chem. 2009, 284:4667-4678.
37. Sugatani T., Vacher J., Hruska K.A. A microRNA expression signature of osteoclastogenesis. Blood 2011, 117:3648-3657.
38. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 2003, 4:638-649.
39. Weilbaecher K.N., Motyckova G., Huber W.E., Takemoto C.M., Hemesath T.J., Xu Y., Hershey C.L., Dowland N.R., Wells A.G., Fisher D.E. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol. Cell 2001, 8:749-758.
40. Weilbaecher K.N., Guise T.A., McCauley L.K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 2011, 11:411-425.
41. Zhang J., Zhao H., Chen J., Xia B., Jin Y., Wei W., Shen J., Huang Y. Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS Lett. 2012, 586:3255-3262.